Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision v3.5.4 was added to the record history, replacing v3.5.3. This reflects a minor update to the page's revision log rather than a change to the study content.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version indicator updates from **v3.5.2** to **v3.5.3**. This reflects a site software/version change rather than a change to the study record content.SummaryDifference0.1%

- Check37 days agoChange DetectedNew history entry on 2026-04-17 includes a Study Status update and Revision: v3.5.2; the previous Revision: v3.5.0 entry dated 2025-10-06 was removed.SummaryDifference0.5%

- Check65 days agoChange DetectedRevision v3.5.0 was added to the revision history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision history updated: added v3.4.3 entry and removed v3.4.2 entry from the Study Record Versions.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded revision entry v3.4.2 to the Record History and removed revision v3.4.1.SummaryDifference0.1%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.